Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Blood Transfusion01:15

Blood Transfusion

Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Being broken: A qualitative study exploring unexpected death in the Paediatric Intensive Care Unit and the family experience of care.

Australian critical care : official journal of the Confederation of Australian Critical Care Nurses·2026
Same author

Excess CMS morbidity and FEMA declarations: Phenome Wide Association Study of Generalized Linear Model interactions between CMS diagnostic code utilization and FEMA Incident types, 1999-2020.

Informatics in medicine unlocked·2025
Same author

Trauma Quality Improvement Program mortality reporting system case reports: Unanticipated mortality because of imaging-related delays in care.

The journal of trauma and acute care surgery·2025
Same author

Smartphone virtual reality for pain management during pediatric burn care transition: study protocol for a randomized controlled trial.

Trials·2025
Same author

Modifiable Areal Unit Problems for Infectious Disease Cases Described in Medicare and Medicaid Claims, 2016-2019.

Journal of bacteriology & parasitology·2024
Same author

Covid-19, Diagnostic History and Mortality from Medicare 1999-2021, In an All-Cause Mortality Approach.

Archives of internal medicine research·2024

Related Experiment Video

Updated: May 17, 2026

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
05:23

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Published on: March 14, 2017

A pediatric massive transfusion protocol.

Sara J Chidester1, Nick Williams, Wei Wang

  • 1Bellevue Hospital Center, Department of Emergency Medicine, New York University, New York, New York, USA.

The Journal of Trauma and Acute Care Surgery
|October 16, 2012
PubMed
Summary

Pediatric massive transfusion protocols (MTPs) reduce thromboembolic events. Coagulopathy often triggers MTP initiation in critically ill children, warranting further research into MTP benefits and objective initiation factors.

More Related Videos

A Modified Sonographic Algorithm for Image Acquisition in Life-Threatening Emergencies in the Critically Ill Newborn
11:27

A Modified Sonographic Algorithm for Image Acquisition in Life-Threatening Emergencies in the Critically Ill Newborn

Published on: April 7, 2023

Related Experiment Videos

Last Updated: May 17, 2026

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
05:23

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Published on: March 14, 2017

A Modified Sonographic Algorithm for Image Acquisition in Life-Threatening Emergencies in the Critically Ill Newborn
11:27

A Modified Sonographic Algorithm for Image Acquisition in Life-Threatening Emergencies in the Critically Ill Newborn

Published on: April 7, 2023

Area of Science:

  • Pediatric critical care medicine
  • Trauma surgery
  • Hematology

Background:

  • Pediatric massive blood transfusions are common, but data on massive transfusion protocols (MTPs) are limited.
  • This study introduces a pediatric MTP and evaluates its impact on patient outcomes.
  • Factors influencing MTP activation were also investigated.

Purpose of the Study:

  • To assess the impact of a pediatric massive transfusion protocol (MTP) on morbidity and mortality.
  • To identify factors associated with the initiation of a pediatric MTP.
  • To compare outcomes between patients managed under an MTP and those receiving transfusions at physician discretion.

Main Methods:

  • Prospective cohort study of pediatric patients requiring un-cross-matched blood.
  • Data collected from January 1, 2009, to January 1, 2011.
  • Comparison of outcomes between MTP and non-MTP groups.

Main Results:

  • No significant difference in mortality between MTP and non-MTP groups.
  • MTP group had a higher Injury Severity Score (42 vs. 25, p ≤ 0.01).
  • Thromboembolic complications were less frequent in the MTP group (p ≤ 0.04).
  • Coagulopathy (PTT > 36) was associated with MTP initiation.

Conclusions:

  • Massive transfusion protocols (MTPs) may minimize coagulopathy in pediatric hemorrhage.
  • MTP use was linked to fewer thromboembolic events.
  • Coagulopathy is a key indicator for MTP activation, suggesting further research is needed.